Browse by topic/sector

64 results found

Results per page:10 20 50

1 - 50 of 64Next

Health and Social Care Procurement (Digital and Data) Baselining - executive summary (2023) This report tests the feasibility of establishing a baseline of health and care procurement spend for digital and data opportunities. Establishing such a baseline will help ensure the accurate evaluat...
Review of the life science and health tech innovation and commercialisation support landscape (2023) This research provides a review of the support ecosystem and the organisations currently providing innovation and commercialisation support to Scottish health innovation life sciences companies (inclu...
Evaluation of the Scottish Co-investment Fund (SCF) and Scottish Venture Fund (SVF) III and IV (2022) The evaluation assesses the performance of the Scottish Co-Investment Fund (SCF) and the Scottish Venture Fund (SVF), covering Phase III and part of Phase IV of the funds’ operation (July 2015 to Marc...
Opportunity for Scottish Pharmaceutical Service Companies in Microbiome Drug Discovery and Development (2022) The microbiome has emerged as a potential untapped therapeutic target in a number of diseases. This work aimed to assess the opportunity for Scottish Pharmaceutical Service companies to provide soluti...
Employee-Owned Business Census 2022 (2022) To undertake a census of all employee-owned businesses (EOB & worker co-operatives) operating in Scotland (as at 5.4.22) to enable policy implementers to track recent developments in the size of the s...
Life Sciences in Scotland Industry Leadership Group Digital & Data Subgroup Opportunities and Priorities – Final Report (2021) The report was commissioned by Scottish Enterprise’s Health for Wealth team on behalf of the Digital and Data subgroup of the Life Sciences Scotland Industry Leadership Group (ILGDD). The work was ove...
Business births, business deaths, and business survival rates analysis (2021) This research provides an overview of trends, taken from Office for National Statistics (ONS) data, of business births, deaths, and survival rates, in Scotland – by local authority, industry and age. ...
Growth businesses in Scotland 2016-20 (2021) This is an update to previous research which considered growth businesses in Scotland from 2011-16. This continues to look further into growth than simply applying the usual ‘high-growth’ definition a...
Epidarex Capital II: Interim Review (2020) In 2013 Scottish Enterprise became a Limited Partner in the Epidarex II Life Sciences Investment Fund. The Fund invests in Life Sciences companies with an emphasis on those spun-out from universities ...
Growth companies in Scotland (2017) This research was designed to identify the nature and extent of growth across the business base in Scotland. It sought to identify the locations in which companies achieve intermittent and sustained g...
Benchmarking Scottish research in life and chemical sciences sectors (2017) The aim of the report was to provide an evaluation of Scotland’s competitive standings in the life and chemical sciences sectors, through a comparison of research and intellectual property indicators ...
Access to notified bodies research and market engagement 2016 (2016) The report outlines a research project undertaken for Scottish Enterprise (SE) between July and October 2016, which sought to understand the challenges faced by Scottish companies around securing the ...
Leadership and management skills challenges within life and chemical sciences sectors (2016) The report presents the findings from a study commissioned by Scottish Enterprise (SE) to help understand the current leadership and management skills gaps within two of their priority sectors – life ...
Analysis of mentoring available to Scottish Life Science companies (2015) This report outlines the findings from a study into mentoring services available to Scottish companies in the Life Sciences sector, based on work undertaken between February and April 2015. The object...
Critical materials: examining the materials that are critical to our sectors and economy (2014) The aim of the report is to provide an understanding of the experiences that companies have in relation to the issue of critical raw materials supply compared to other supply chain issues. It also see...
Evaluation of Enterprise Fellowships: final report (2013) Scottish Enterprise (SE) and the Royal Society of Edinburgh’s (RSE’s) Enterprise Fellowships programme aims to target researchers and innovators with entrepreneurial potential and a promising science ...
High growth and high technology firms in Scotland (2012) The report looks at the latest Scottish data on high growth firms (HGFs), which have 10 or more employees and have achieved three consecutive years of employment or turnover growth of more than twenty...
Evaluation of Scottish Stem Cell Network (SSCN): final report (2012) The Scottish Stem Cell Network (SSCN) aims to create an over-arching body for interventions supporting the stem cell network. It encourages collaborative links between research scientists, clinicians,...
Evaluation of the Wellness and Health Innovation project (2011) The Wellness and Health Innovation (WHI) project provides specialised support to Scottish companies that are developing innovative technology-enabled products, services or applications for the growing...
Evaluation of SE funded pre commercial research projects: the Commercialisation Awards (2011) The Commercialisation Awards (CAs) were small scale grants made available to the University of Dundee and the Scottish Crop Research Institute to take forward a specific piece of research with commerc...
Evaluation of SE funded pre commercial research projects: the Stem Cell Translational Fund (2011) The Stem Cell Translational Fund (SCTF) is a ring fenced £5 million fund established by Scottish Enterprise (SE) to match fund translational stem cell activity. Its main purpose is to further the clin...
Evaluation of Nexxus (2011) Nexxus was first launched in 2003 within the West of Scotland as a Life Sciences (LS) networking organisation. Its remit was extended to the East of Scotland in 2008. The project promotes and supports...
Evaluation of Scottish Bioinformatics Forum (2010) The Scottish Bioinformatics Forum (SBF) is designed to raise awareness, promote collaboration and enhance the life sciences sector in Scotland. The SBF is jointly funded through the Scottish Funding C...
Translational and clinical medicine study: report to Scottish Enterprise (2010) This study of translational and clinical medicine (TCM) in Scotland was conducted to: assess progress to date and areas of likely future impact of current TCM-related interventions supported by Scotti...
Equality and diversity baseline information on Scotland’s key economic sectors (2010) This report establishes an equality and diversity baseline for Scotland’s key economic sectors, forming part of the ongoing work of Scottish Enterprise (SE) and Highlands and Islands Enterprise (HIE) ...
Life science innovation strategies in Sweden, Ireland and Ontario: lessons learned for Scotland (2010) The research was conducted in order to help put Scottish life science policy efforts in context with other countries and regions around the world. Focusing on Sweden, Ireland and Ontario, it aimed to ...
Immunotherapy: environmental scan (2009) Immunotherapy is defined broadly as a set of clinical interventions aimed at counteracting disease by modulating a patient’s immune system, using both conventional small molecule approaches and tools ...
Phase 1 Life Sciences Innovation Facility, Foresterhill Campus, Aberdeen: learning review report (2009) Scottish Enterprise (SE) commissioned a learning review of its involvement in phase one of the Life Sciences Innovation Facility (LSIF) at the University of Aberdeen’s (UoA’s) Foresterhill Campus. Th...
Evaluation of the GTI Business Connections Project: final report (2009) The centre for Genomics Technology and Informatics (GTI) Business Connections project (‘the Business Connections project’) was developed by the University of Edinburgh and Scottish Enterprise Edinburg...
Edinburgh Pre Incubation Scheme economic impact evaluation: final report (2009) The Edinburgh Pre-Incubator Scheme (EPIS) aims to encourage and support innovation by facilitating direct collaboration between universities and entrepreneurs. The primary focus of this evaluation was...
Next generation crops: foresighting (2008) Genetic modification (GM) of plants aims to introduce trait-related genes through the genetic engineering of plant material. The report looked specifically at the market for improved seeds for communi...
Plant biotechnology and its many markets: environmental scan (2008) This report aimed to examine the existing and potential application of modern biotechnology, as applied to plant life. It looked specifically at the potential role of agricultural biotech in the produ...
Drug delivery: foresighting report (2008) Advances in ‘drug delivery’ aim to improve the delivery, performance or safety of a therapeutic product. The report focuses on four areas within drug delivery: transdermal, microcapsules, nanoparticle...
Minimally invasive medical devices: environmental scan - technology and markets (2008) The report aimed to identify sectors where reductions in the invasiveness of key technology could significantly impact the medical device market. In this context, minimally invasive devices are those ...
Wound healing: foresighting report - technology and markets (2008) The advanced wound management market targets hard-to-heal and chronic wounds, such as diabetic foot ulcers, that are growing in prevalence. There is a need for more clinically effective products to ac...
Transport infrastructure and services: industry views (2008) The Scottish Government’s Economic Strategy identifies transport as one of the key factors in promoting economic growth in those sectors identified as having significant growth potential: energy, fina...
Stem Cell Monitoring and Evaluation Framework: final report (2008) The Scottish Stem Cell Intervention Framework (SCIF) is a joint venture supported by the Scottish Government, Scottish Enterprise (SE), universities, private companies and individuals, the aim of whic...
Evaluation of TalentScotland: report for Scottish Enterprise (2008) TalentScotland was created as a pilot project in 2001 to address skills gap issues critical to the growth of design electronics activity in Scotland. Life science, Financial Services and the Energy Se...
Evaluation of NEXXUS: the West of Scotland Bioscience Network (2008) NEXXUS was formed in 2003 with the aim of: facilitating communication, knowledge sharing and collaboration between organisations involved in life sciences and related activities in the West of Scotlan...
Review of LSBAS: report for Scottish Enterprise Glasgow (2008) The Life Sciences Business Advisory Service (LSBAS) aims to provide advice and support to aid in the formation, development and growth of life sciences companies in Scotland, with funding support from...
Synthetic biology: foresighting - technologies and markets (2007) Synthetic biology is the application of engineering concepts to the construction of biological systems. It has potential applications in the fields of bioenergy, drug development, chemical synthesis a...
Emerging drug targets: ubiquitin signalling - market foresighting (2007) Ubiquitin is a highly conserved 76 amio acid and 8.5kDa polypeptide: the level of ubiquitination influences and controls key cellular processes, suggesting that the modulation of the ubiquitin proteas...
Non-invasive medical devices: environmental scan - technology and markets (2007) Non-invasive medical devices can be defined as those which do not require insertion into any part of the patient’s body for diagnosis, monitoring or treatment of disease. Non-invasive techniques offer...
Review of the Scottish Enterprise and Royal Society of Edinburgh Enterprise Fellowship Programme: independent review of business performance and economic impact - executive summary (2007) Scottish Enterprise commissioned an independent review of the Scottish Enterprise and Royal Society of Edinburgh Enterprise Fellowship Programme, to evaluate the performance of businesses which emerge...
Evaluation of BioDundee (2007) BioDundee is a partnership between the public, private and academic sectors in the Dundee area to support and promote the life sciences sector. Its objectives involve the provision of opportunities f...
Market foresighting: liquid biofuels (2006) Biofuels are a renewable natural fuel source which have the potential to serve as alternative to fossil based fuels. The report focused on liquid biofuels, which depend on feedstocks from agricultural...
Emerging drug targets: environmental scan (2006) The report aimed to identify key emerging drug targets of the future. It aimed to provide accurate predictions of emerging targets, in order to allow ITI Life Sciences to match future funded programme...
Synthetic biology: environmental scan - technologies and markets (2006) The report defines synthetic biology as either the design and construction of new biological parts, devices and systems or the re-design of existing, natural biological systems for useful purposes. Th...
Therapeutic and diagnostic antibody sector: current status and future directions (2006) Monoclonal antibodies (mabs) are monospecific antibodies that are artificially produced from particular substances in order to detect or purify those substances. They are important tools in biochemist...
Market foresighting: molecular imaging (2006) Molecular imaging is an interdisciplinary field focused on the non invasive measurement and characterisation of biological, cellular, and molecular processes as they occur in living organisms. This ma...

Health and Social Care Procurement (Digital and Data) Baselining - executive summary (2023) This report tests the feasibility of establishing a baseline of health and care procurement spend for digital and data opportunities. Establishing such a baseline will help ensure the accurate evaluat...

Review of the life science and health tech innovation and commercialisation support landscape (2023) This research provides a review of the support ecosystem and the organisations currently providing innovation and commercialisation support to Scottish health innovation life sciences companies (inclu...

Evaluation of the Scottish Co-investment Fund (SCF) and Scottish Venture Fund (SVF) III and IV (2022) The evaluation assesses the performance of the Scottish Co-Investment Fund (SCF) and the Scottish Venture Fund (SVF), covering Phase III and part of Phase IV of the funds’ operation (July 2015 to Marc...

Opportunity for Scottish Pharmaceutical Service Companies in Microbiome Drug Discovery and Development (2022) The microbiome has emerged as a potential untapped therapeutic target in a number of diseases. This work aimed to assess the opportunity for Scottish Pharmaceutical Service companies to provide soluti...

Employee-Owned Business Census 2022 (2022) To undertake a census of all employee-owned businesses (EOB & worker co-operatives) operating in Scotland (as at 5.4.22) to enable policy implementers to track recent developments in the size of the s...

Life Sciences in Scotland Industry Leadership Group Digital & Data Subgroup Opportunities and Priorities – Final Report (2021) The report was commissioned by Scottish Enterprise’s Health for Wealth team on behalf of the Digital and Data subgroup of the Life Sciences Scotland Industry Leadership Group (ILGDD). The work was ove...

Business births, business deaths, and business survival rates analysis (2021) This research provides an overview of trends, taken from Office for National Statistics (ONS) data, of business births, deaths, and survival rates, in Scotland – by local authority, industry and age. ...

Growth businesses in Scotland 2016-20 (2021) This is an update to previous research which considered growth businesses in Scotland from 2011-16. This continues to look further into growth than simply applying the usual ‘high-growth’ definition a...

Epidarex Capital II: Interim Review (2020) In 2013 Scottish Enterprise became a Limited Partner in the Epidarex II Life Sciences Investment Fund. The Fund invests in Life Sciences companies with an emphasis on those spun-out from universities ...

Growth companies in Scotland (2017) This research was designed to identify the nature and extent of growth across the business base in Scotland. It sought to identify the locations in which companies achieve intermittent and sustained g...

Benchmarking Scottish research in life and chemical sciences sectors (2017) The aim of the report was to provide an evaluation of Scotland’s competitive standings in the life and chemical sciences sectors, through a comparison of research and intellectual property indicators ...

Access to notified bodies research and market engagement 2016 (2016) The report outlines a research project undertaken for Scottish Enterprise (SE) between July and October 2016, which sought to understand the challenges faced by Scottish companies around securing the ...

Leadership and management skills challenges within life and chemical sciences sectors (2016) The report presents the findings from a study commissioned by Scottish Enterprise (SE) to help understand the current leadership and management skills gaps within two of their priority sectors – life ...

Analysis of mentoring available to Scottish Life Science companies (2015) This report outlines the findings from a study into mentoring services available to Scottish companies in the Life Sciences sector, based on work undertaken between February and April 2015. The object...

Critical materials: examining the materials that are critical to our sectors and economy (2014) The aim of the report is to provide an understanding of the experiences that companies have in relation to the issue of critical raw materials supply compared to other supply chain issues. It also see...

Evaluation of Enterprise Fellowships: final report (2013) Scottish Enterprise (SE) and the Royal Society of Edinburgh’s (RSE’s) Enterprise Fellowships programme aims to target researchers and innovators with entrepreneurial potential and a promising science ...

High growth and high technology firms in Scotland (2012) The report looks at the latest Scottish data on high growth firms (HGFs), which have 10 or more employees and have achieved three consecutive years of employment or turnover growth of more than twenty...

Evaluation of Scottish Stem Cell Network (SSCN): final report (2012) The Scottish Stem Cell Network (SSCN) aims to create an over-arching body for interventions supporting the stem cell network. It encourages collaborative links between research scientists, clinicians,...

Evaluation of the Wellness and Health Innovation project (2011) The Wellness and Health Innovation (WHI) project provides specialised support to Scottish companies that are developing innovative technology-enabled products, services or applications for the growing...

Evaluation of SE funded pre commercial research projects: the Commercialisation Awards (2011) The Commercialisation Awards (CAs) were small scale grants made available to the University of Dundee and the Scottish Crop Research Institute to take forward a specific piece of research with commerc...

Evaluation of SE funded pre commercial research projects: the Stem Cell Translational Fund (2011) The Stem Cell Translational Fund (SCTF) is a ring fenced £5 million fund established by Scottish Enterprise (SE) to match fund translational stem cell activity. Its main purpose is to further the clin...

Evaluation of Nexxus (2011) Nexxus was first launched in 2003 within the West of Scotland as a Life Sciences (LS) networking organisation. Its remit was extended to the East of Scotland in 2008. The project promotes and supports...

Evaluation of Scottish Bioinformatics Forum (2010) The Scottish Bioinformatics Forum (SBF) is designed to raise awareness, promote collaboration and enhance the life sciences sector in Scotland. The SBF is jointly funded through the Scottish Funding C...

Translational and clinical medicine study: report to Scottish Enterprise (2010) This study of translational and clinical medicine (TCM) in Scotland was conducted to: assess progress to date and areas of likely future impact of current TCM-related interventions supported by Scotti...

Equality and diversity baseline information on Scotland’s key economic sectors (2010) This report establishes an equality and diversity baseline for Scotland’s key economic sectors, forming part of the ongoing work of Scottish Enterprise (SE) and Highlands and Islands Enterprise (HIE) ...

Life science innovation strategies in Sweden, Ireland and Ontario: lessons learned for Scotland (2010) The research was conducted in order to help put Scottish life science policy efforts in context with other countries and regions around the world. Focusing on Sweden, Ireland and Ontario, it aimed to ...

Immunotherapy: environmental scan (2009) Immunotherapy is defined broadly as a set of clinical interventions aimed at counteracting disease by modulating a patient’s immune system, using both conventional small molecule approaches and tools ...

Phase 1 Life Sciences Innovation Facility, Foresterhill Campus, Aberdeen: learning review report (2009) Scottish Enterprise (SE) commissioned a learning review of its involvement in phase one of the Life Sciences Innovation Facility (LSIF) at the University of Aberdeen’s (UoA’s) Foresterhill Campus. Th...

Evaluation of the GTI Business Connections Project: final report (2009) The centre for Genomics Technology and Informatics (GTI) Business Connections project (‘the Business Connections project’) was developed by the University of Edinburgh and Scottish Enterprise Edinburg...

Edinburgh Pre Incubation Scheme economic impact evaluation: final report (2009) The Edinburgh Pre-Incubator Scheme (EPIS) aims to encourage and support innovation by facilitating direct collaboration between universities and entrepreneurs. The primary focus of this evaluation was...

Next generation crops: foresighting (2008) Genetic modification (GM) of plants aims to introduce trait-related genes through the genetic engineering of plant material. The report looked specifically at the market for improved seeds for communi...

Plant biotechnology and its many markets: environmental scan (2008) This report aimed to examine the existing and potential application of modern biotechnology, as applied to plant life. It looked specifically at the potential role of agricultural biotech in the produ...

Drug delivery: foresighting report (2008) Advances in ‘drug delivery’ aim to improve the delivery, performance or safety of a therapeutic product. The report focuses on four areas within drug delivery: transdermal, microcapsules, nanoparticle...

Minimally invasive medical devices: environmental scan - technology and markets (2008) The report aimed to identify sectors where reductions in the invasiveness of key technology could significantly impact the medical device market. In this context, minimally invasive devices are those ...

Wound healing: foresighting report - technology and markets (2008) The advanced wound management market targets hard-to-heal and chronic wounds, such as diabetic foot ulcers, that are growing in prevalence. There is a need for more clinically effective products to ac...

Transport infrastructure and services: industry views (2008) The Scottish Government’s Economic Strategy identifies transport as one of the key factors in promoting economic growth in those sectors identified as having significant growth potential: energy, fina...

Stem Cell Monitoring and Evaluation Framework: final report (2008) The Scottish Stem Cell Intervention Framework (SCIF) is a joint venture supported by the Scottish Government, Scottish Enterprise (SE), universities, private companies and individuals, the aim of whic...

Evaluation of TalentScotland: report for Scottish Enterprise (2008) TalentScotland was created as a pilot project in 2001 to address skills gap issues critical to the growth of design electronics activity in Scotland. Life science, Financial Services and the Energy Se...

Evaluation of NEXXUS: the West of Scotland Bioscience Network (2008) NEXXUS was formed in 2003 with the aim of: facilitating communication, knowledge sharing and collaboration between organisations involved in life sciences and related activities in the West of Scotlan...

Review of LSBAS: report for Scottish Enterprise Glasgow (2008) The Life Sciences Business Advisory Service (LSBAS) aims to provide advice and support to aid in the formation, development and growth of life sciences companies in Scotland, with funding support from...

Synthetic biology: foresighting - technologies and markets (2007) Synthetic biology is the application of engineering concepts to the construction of biological systems. It has potential applications in the fields of bioenergy, drug development, chemical synthesis a...

Emerging drug targets: ubiquitin signalling - market foresighting (2007) Ubiquitin is a highly conserved 76 amio acid and 8.5kDa polypeptide: the level of ubiquitination influences and controls key cellular processes, suggesting that the modulation of the ubiquitin proteas...

Non-invasive medical devices: environmental scan - technology and markets (2007) Non-invasive medical devices can be defined as those which do not require insertion into any part of the patient’s body for diagnosis, monitoring or treatment of disease. Non-invasive techniques offer...

Review of the Scottish Enterprise and Royal Society of Edinburgh Enterprise Fellowship Programme: independent review of business performance and economic impact - executive summary (2007) Scottish Enterprise commissioned an independent review of the Scottish Enterprise and Royal Society of Edinburgh Enterprise Fellowship Programme, to evaluate the performance of businesses which emerge...

Evaluation of BioDundee (2007) BioDundee is a partnership between the public, private and academic sectors in the Dundee area to support and promote the life sciences sector. Its objectives involve the provision of opportunities f...

Market foresighting: liquid biofuels (2006) Biofuels are a renewable natural fuel source which have the potential to serve as alternative to fossil based fuels. The report focused on liquid biofuels, which depend on feedstocks from agricultural...

Emerging drug targets: environmental scan (2006) The report aimed to identify key emerging drug targets of the future. It aimed to provide accurate predictions of emerging targets, in order to allow ITI Life Sciences to match future funded programme...

Synthetic biology: environmental scan - technologies and markets (2006) The report defines synthetic biology as either the design and construction of new biological parts, devices and systems or the re-design of existing, natural biological systems for useful purposes. Th...

Therapeutic and diagnostic antibody sector: current status and future directions (2006) Monoclonal antibodies (mabs) are monospecific antibodies that are artificially produced from particular substances in order to detect or purify those substances. They are important tools in biochemist...

Market foresighting: molecular imaging (2006) Molecular imaging is an interdisciplinary field focused on the non invasive measurement and characterisation of biological, cellular, and molecular processes as they occur in living organisms. This ma...

Browse Navigation